Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TGTX
TGTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TGTX News
TG Therapeutics Q2 Earnings Outlook Focuses on Briumvi
1d ago
stocktwits
TG Therapeutics Initiates Phase 2 Trial for BRIUMVI in Treatment-Resistant Schizophrenia
2d ago
Newsfilter
Analysis of XBI ETF Trading Dynamics
Jun 24 2026
NASDAQ.COM
Quantum BioPharma Advances Novel MS Drug Candidate Lucid-MS
Jun 24 2026
Globenewswire
Quantum BioPharma Advances Novel MS Drug Candidate Lucid-MS into Phase 2 Trials
Jun 24 2026
Newsfilter
TG Therapeutics Reports Positive Results for Subcutaneous BRIUMVI
Jun 17 2026
stocktwits
Trump's New Attacks on Iran Drive Oil Prices Up
Jun 11 2026
Yahoo Finance
Stock Market Volatility Driven by AI Fears and Trump's Iran Threats
Jun 09 2026
Yahoo Finance
TG Therapeutics Reports Positive Early Results for BRIUMVI in Myasthenia Gravis
Jun 09 2026
stocktwits
TG Therapeutics Reports Positive Phase 1 Data for BRIUMVI in Myasthenia Gravis
Jun 09 2026
NASDAQ.COM
TG Therapeutics Initiates Pivotal Mid-Stage Trial for Briumvi in Myasthenia Gravis
Jun 09 2026
seekingalpha
BRIUMVI Shows Positive Phase 1 Results in Myasthenia Gravis Trial
Jun 09 2026
Newsfilter
Broadcom and CrowdStrike Shares Drop Post Earnings
Jun 04 2026
Yahoo Finance
TG Therapeutics Shares Rise 10% on Positive Trial Data for Briumvi
Jun 03 2026
seekingalpha
TG Therapeutics Reports Positive Clinical Data for Briumvi Injectable Formulation
Jun 03 2026
stocktwits
Positive Progress in BRIUMVI Subcutaneous Dosing Study
Jun 03 2026
Newsfilter
Show More News
